Waters Corporation

338 articles with Waters Corporation

• 

  The 12 Top Biopharma Companies Hiring Now

  6/8/2022

  According to recent BioSpace research, diversity and inclusion is an important factor when considering a new employment opportunity for 85% of life sciences community members.

• Waters Introduces High Resolution Mass Spectrometry Products and Software to Accelerate Drug Development

  6/6/2022

  ASMS 2022 – Waters Corporation unveiled new instruments, software and product enhancements to drive drug discovery and development at the American Society for Mass Spectrometry 2022 Annual Conference.

• Waters Corporation Presentation at the Jefferies 2022 Global Health Care Conference

  5/26/2022

  Waters Corporation Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies 2022 Global Healthcare Conference in New York City on Wednesday, June 8th, 2022 at 4:30PM Eastern Standard Time.

• Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab

  5/5/2022

  Waters Corporation and The University of Delaware announced the grand opening of Immerse™ Delaware, a new Waters innovation and research laboratory.

• Waters Corporation (NYSE: WAT) Reports First Quarter 2022 Financial Results

  5/3/2022

  Waters Corporation (NYSE: WAT) today announced its financial results for the first quarter of 2022.

• Waters Corporation to Host Investor Day

  4/19/2022

  Waters Corporation (NYSE:WAT) announced today that it will host its 2022 Investor Day on Thursday, May 19, 2022, starting at 8:45 a.m. (ET) at the New York Stock Exchange, 11 Wall St, New York, NY 10005.

• Waters Introduces Xevo TQ Absolute – The Most Sensitive and Compact Benchtop Tandem Quadrupole Mass Spectrometer

  3/31/2022

  Waters Corporation introduced the new Xevo™ TQ Absolute system, the most sensitive and compact benchtop tandem mass spec in its class.i This press release features multimedia.

• Waters Introduces Faster, Reliable and Automated Solution for Mass and Purity Analysis of Biomolecules

  3/22/2022

  Waters Corporation introduced new software and analytical columns to aid biomolecule drug discovery and development.

• Waters Corporation Presentation at the Cowen 42nd Annual Health Care Conference

  2/25/2022

  Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Cowen Healthcare Conference on Wednesday, March 9th, 2022 at 2:10PM Eastern Standard Time.

• Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2021 Financial Results

  2/1/2022

  Waters Corporation (NYSE: WAT) today announced fourth quarter 2021 sales of $836 million, an increase of 6% as reported and 8% in constant currency, compared to sales of $787 million for the fourth quarter of 2020.

• Waters Acquires Charge Detection Mass Spectrometry Technology to Broaden its Application in Cell and Gene Therapy

  2/1/2022

  Waters has acquired technology assets and intellectual property rights of Megadalton Solutions, an early-stage developer of charge detection mass spectrometry (CDMS).

• U.S. Food and Drug Administration Expands Deployment of Waters Corporation Software to Support its Medical Products Testing Labs

  1/24/2022

  Waters Corporation announced the U.S. Food and Drug Administration’s Office of Regulatory Affairs has purchased Waters™ Empower™ Chromatography Data Software and NuGenesis™ Laboratory Management Software, expanding its deployment of Waters’ software to support its medical products testing operations across its five field science laboratories.

• Waters Corporation Q4 2021 Financial Results Webcast Invitation

  1/12/2022

  Waters Corporation will webcast its Q4 2021 financial results conference call live on Tuesday, February 1st 2022 at 8:00 a.m. eastern time.

• Waters Accelerates Quantitative Mass Spectrometry With New Application on waters_connect Informatics Platform

  1/12/2022

  Waters Corporation announced it is expanding its waters_connect™ informatics software platform to support customers analyzing food and environmental samples with Waters’ tandem quadrupole mass spectrometers.

• Waters Corporation Presentation at the 40th Annual J.P. Morgan Healthcare Conference to be Webcast Live

  12/20/2021

  Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will speak to the investment community at the J.P. Morgan Healthcare Conference virtually on Monday, January 10th, 2022 at 8:15AM Eastern Standard Time.

• Waters Corporation Presentation at the Evercore ISI HealthCONx 2021 Virtual Health Care Conference to Be Webcast Live

  11/17/2021

  Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will speak to the investment community at the Evercore ISI 4th Annual HealthCONx Healthcare Conference virtually on Tuesday, November 30th, 2021 at 12:10PM Eastern Standard Time.

• Waters Corporation (NYSE: WAT) Reports Third Quarter 2021 Financial Results

  11/2/2021

  Waters Corporation (NYSE: WAT) today announced third quarter 2021 sales of $659 million, an 11% increase as reported, compared to sales of $594 million for the third quarter of 2020.

• Waters Corporation Appoints John M. Ballbach to Board of Directors

  10/6/2021

  Waters Corporation (NYSE:WAT) today announced the appointment of John M. Ballbach to its Board of Directors, effective October 5, 2021.

• Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals

  9/14/2021

  Waters Corporation (NYSE:WAT) today introduced the Waters™ BioAccord™ System with ACQUITY™ Premier, a combination of the Waters BioAccord System and the breakthrough ACQUITY Premier UPLC™ with MaxPeak™ High Performance Surface (HPS) technology.

• Waters to Present at the Bank of America Global Healthcare Conference 2021

  9/2/2021

  Waters Corporation Udit Batra Ph.D., President and Chief Executive Officer, will present at the Bank of America Global Healthcare Conference 2021 virtually on Thursday, September 16th, 2021 at 3:55PM BST / 10:55AM Eastern Time.